3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
19
Polycystic Ovary Syndrome
10
Prostatic Neoplasms
7
Breast Neoplasms
6
Neoplasms
5
Colorectal Neoplasms
4
Insulin Resistance
3
Lung Neoplasms
2
Fatigue
2
Esophageal Neoplasms
2
Cardiotoxicity
2
Stomach Neoplasms
1
Rectal Neoplasms
1
Primary Dysautonomias
1
Pediatric Brain Tumor
1
Ovarian Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Follicular
1
Lupus Erythematosus, Systemic
1
Inflammation
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Disease
1
Diabetes Mellitus, Type 1
1
Chemotherapy-Related Cognitive Impairment
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
Cachexia
1
Interventions
Radiosurgery
24
lenvatinib
19
Radiofrequency Ablation
16
Hepatectomy
13
Sorafenib
12
Radiotherapy
9
Surgical Procedures, Operative
8
Magnetic Resonance Spectroscopy
7
Bevacizumab
7
sintilimab
6
camrelizumab
6
Immune Checkpoint Inhibitors
6
Electroporation
6
Blood Specimen Collection
6
atezolizumab
5
apatinib
5
tislelizumab
4
Yttrium-90
4
Proton Therapy
4
Oxaliplatin
4
Liver Transplantation
4
Doxorubicin
4
Control Groups
4
Cisplatin
4
Chemoembolization, Therapeutic
4
Catheter Ablation
4
spartalizumab
3
entecavir
3
X-Rays
3
Standard of Care
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Carcinoma, Hepatocellular
×
High-Intensity Interval Training
×
Clear all
NCT03518632
2022-07-19
APACHE
Centre Hospitalier Universitaire de Besancon
Phase NA
Completed
8 enrolled